Skip to Content

Taro Pharmaceutical Industries Ltd TARO

Morningstar Rating
$42.10 +0.03 (0.07%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TARO is trading at a 19% discount.
Price
$42.05
Fair Value
$25.48
Uncertainty
High
1-Star Price
$79.69
5-Star Price
$74.12
Economic Moat
Wpfy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TARO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$42.07
Day Range
$42.0042.24
52-Week Range
$22.8943.40
Bid/Ask
$41.90 / $42.49
Market Cap
$1.58 Bil
Volume/Avg
57,343 / 54,219

Key Statistics

Price/Earnings (Normalized)
33.48
Price/Sales
2.59
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
1,554

Competitors

Valuation

Metric
TARO
PRGO
TEVA
Price/Earnings (Normalized)
33.4810.215.27
Price/Book Value
0.890.752.02
Price/Sales
2.590.770.95
Price/Cash Flow
20.647.6810.49
Price/Earnings
TARO
PRGO
TEVA

Financial Strength

Metric
TARO
PRGO
TEVA
Quick Ratio
3.030.940.54
Current Ratio
3.601.791.02
Interest Coverage
0.950.39
Quick Ratio
TARO
PRGO
TEVA

Profitability

Metric
TARO
PRGO
TEVA
Return on Assets (Normalized)
2.15%3.23%6.70%
Return on Equity (Normalized)
2.62%7.32%39.00%
Return on Invested Capital (Normalized)
0.92%5.60%13.54%
Return on Assets
TARO
PRGO
TEVA
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AKgrl$87.4 Bil
MKKGY
Merck KGaA ADRTnszzm$74.3 Bil
HLN
Haleon PLC ADRSmyf$38.5 Bil
VTRS
Viatris IncVvw$15.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHlxr$12.4 Bil
CTLT
Catalent IncZtfpfb$10.3 Bil
CURLF
Curaleaf Holdings IncQcv$3.6 Bil
PRGO
Perrigo Co PLCQgddm$3.6 Bil
PBH
Prestige Consumer Healthcare IncGkqqxkf$3.5 Bil
GTBIF
Green Thumb Industries IncRbmjg$3.1 Bil

Sponsor Center